The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.
May 4, 2022
0
107
The U.S. Food and Drug Administration on Tuesday approved the antiviral remdesivir as the first COVID-19 treatment for young children.
Apr 26, 2022
0
5
Scientists at the University of North Carolina at Chapel Hill are testing a new route for remdesivir, a pill form of the COVID-19 treatment that's given to half of all hospitalized patients with the disease.
Mar 22, 2022
0
79
Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.
Mar 9, 2022
0
153
In a living systematic review and updated article published online March 1 in the Annals of Internal Medicine, final practice points are presented for use of remdesivir for hospitalized patients with COVID-19.
Mar 1, 2022
0
15
Researchers have identified a powerful combination of antivirals to treat COVID-19. Combining the drug brequniar with remdesivir or molnupiravir—both approved by the U.S. Food and Drug Administration for emergency use—inhibited ...
Feb 7, 2022
0
454
A clinical trial has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, is not more effective than remdesivir alone for treating ...
Jan 28, 2022
0
69
Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University ...
Jan 18, 2022
0
129
New research shows for the first time why the antiviral drug remdesivir works against some viruses but not others—a finding that improves our understanding of how antiviral drugs interact with viruses at a molecular level, ...
Jan 13, 2022
0
19
A three-day course of remdesivir results in a lower risk for hospitalization or death compered with placebo among nonhospitalized patients at high risk for COVID-19 progression, according to a study published online Dec. ...
Dec 29, 2021
0
25
